Urological Cancer

Although very common, urological cancers rarely receive headline acknowledgement. In the developed world, prostate cancer continues to increase in both incidence and prevalence and is now the second leading cause of cancer death in the UK. In addition, testicular cancers are also increasing and bladder tumours are becoming more common in women. Advances in cancer treatment, in some cases initiated in the field of urology, have dramatically changed the way some cancers are handled. Chemotherapy has transformed survival in testicular cancer and cytokines are active in renal cell cancer, while intravesical BCG treatment plays a significant role in the management of bladder cancer. Aimed at all health professionals working in urological oncology, Urological Cancer provides comprehensive yet concise diagnostic, radiotherapeutic and surgical overviews of urological tumours, malignant and benign.